Product Information
FLUVOXAMINE MALEATE 50 MG TAB is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.1954 per EA under NDC 62559015901. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Dec 20, 2007. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
50 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559015901
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FLUVOXAMINE MALEATEApproval Type
Authorized Generic (NDA)
FDA Application
NDA021519FDA Approved
12/20/2007
TE Code
AB
On Market Since
8/9/2011
Pharmacological Classes
Price Statistics
The NADAC for FLUVOXAMINE MALEATE 50 MG TAB has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 24.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1954 per EA |
|---|---|
| All-time high | $0.4614 (Apr 15, 2020) |
| All-time low | $0.1592 (Nov 20, 2024) |
| 52-week high | $0.2389 |
| 52-week low | $0.1954 |
| Median price | $0.2625 |
| Average price | $0.2898 |
| Largest weekly change | +32.4% (Oct 18, 2017) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Fluvoxamine maleate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FLUVOXAMINE MALEATE 50 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for FLUVOXAMINE MALEATE 50 MG TAB, manufactured by ANI Pharmaceuticals, Inc., is $0.1954 per EA (NDC 62559015901), effective Sep 30, 2026.
How has the price of FLUVOXAMINE MALEATE 50 MG TAB changed over time?
Over the history we have for it, the NADAC for FLUVOXAMINE MALEATE 50 MG TAB has declined 24.3%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FLUVOXAMINE MALEATE 50 MG TAB?
Since Nov 28, 2013, the NADAC for FLUVOXAMINE MALEATE 50 MG TAB has ranged from a low of $0.1592 (Nov 20, 2024) to a high of $0.4614 (Apr 15, 2020), with a median of $0.2625 per EA.
Are there cheaper alternatives to FLUVOXAMINE MALEATE 50 MG TAB?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FLUVOXAMINE MALEATE 50 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures FLUVOXAMINE MALEATE 50 MG TAB?
FLUVOXAMINE MALEATE 50 MG TAB (NDC 62559015901) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.